(redirected from hypophosphatemia)
Also found in: Medical, Encyclopedia, Wikipedia.
Related to hypophosphatemia: hypophosphatasia


 (fŏs′fə-to͝or′ē-ə, -tyo͝or′-)
An excess of phosphates in the urine.

phos′pha·tu′ric adj.


(Pathology) pathol an abnormally large amount of phosphates in the urine
[C19: New Latin, from phosphate + -uria]
ˌphosphaˈturic adj


(ˌfɒs fəˈtʊər i ə, -ˈtyʊər-)

the presence of an excessive quantity of phosphates in the urine.
References in periodicals archive ?
Ltd,, Kyowa Kirin International PLC and Ultragenyx Pharmaceutical announce that Crysvita has received a positive European Commission decision granting a conditional marketing authorisation to Kyowa Kirin for the treatment of X-linked hypophosphatemia with radiographic evidence of bone disease in children 1 year of age and older and adolescents with growing skeletons.
The most frequent all causality Grade 3-4 adverse reactions (>=5%) in patients treated with Cabometyx were hypertension, diarrhea, hyponatremia, hypophosphatemia, palmar-plantar erythrodysesthesia, fatigue, increased ALT, decreased appetite, stomatitis, pain, hypotension, and syncope.
Patients with hypophosphatemia, hyperparathyroidism, postmenopausal women and male patients older than 50, as indicated in the current HIV infection management guidelines were recruited for the study.
Other clinically relevant abnormalities were a moderate, proportional hyponatremia and hypochloridemia, moderate to marked hypocalcemia and hypophosphatemia, mild hyperuricemia, and hyperglycemia.
Biochemical tests may reveal hypokalemia, metabolic acidosis, hypophosphatemia, hypocalcemia, low carnitine level, and hyponatremia.
The main complications of RM are acute kidney failure, electrolyte imbalance, especially hyperkalemia which leads to arrhythmia, hypophosphatemia and hypocalcaemia.
1,7) A study found that cutaneous skeletal hypophosphatemia syndrome, manifested as NS and vitamin D-resistant rickets, has identical ras mutations in both skin and bone tissues, providing further support that these syndromic findings are a result of a multilineage somatic ras mutation.
5% of the patients with hypophosphatemia were still under the treatment of PBs [Figure 1].
Severe hypophosphatemia (plasma phosphate concentration < 1 mg/dL) is an extremely serious medical condition that can result in muscle weakness, mental status changes, rhabdomyolysis, and respiratory failure (1, 2).
Exclusion criteria were vitamin D supplementation in recent month, patients with renal failure, parathyroid disorders, pregnant women, disability, sarcoidosis, rickets and hypophosphatemia, heart valve surgery, Rheumatic and Nonrheumatic Valvular Heart Disease ([greater than or equal to]moderate), Redo operation and patients with a history of AF.
M2 EQUITYBITES-July 29, 2016-Ultragenyx concludes X-Linked Hypophosphatemia adult patient admission in Phase 3 Study of KRN23